Partnering for New Profilers.

Skyline Diagnostics is the your partner of choice to transform gene signatures into a clinical tools. We are a leading company in translational development of gene signature-based diagnostics. Skyline markets its own diagnostic microarrays (Profilers) and collaborates with academic and industrial partners to launch develop and market new products. We have extensive expertise in biomedical sciences, bioinformatics, regulatory affairs and clinical trial organization. Our adherence to stringent quality systems assures product safety, efficacy and robust results.

  • skyline 60200px

    Development of new profilers

    As an innovative company, Skyline is actively seeking academic and industrial partners for development of novel diagnostic products. If you have developed a diagnostic signature, published or unpublished, we will screen it in one month against a comprehensive set of criteria.

    Read more
     
  • skyline 119200px

    Development of Companion Diagnostics

    Being able to stratify patients to qualify for use of a given drug is rapidly becoming as important as traditional pharmacological and toxicological properties of that drug. Skyline is your partner of choice to develop gene signature-based assays to identify patient groups with favorable drug response profiles.

    Read more
     

Dr. Molewaterplein 50, Suite Ee1971, 3015 GE Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com